Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Immunotherapy for Brain Tumors.

Sampson JH, Maus MV, June CH.

J Clin Oncol. 2017 Jul 20;35(21):2450-2456. doi: 10.1200/JCO.2017.72.8089. Epub 2017 Jun 22. Review.

PMID:
28640704
2.

Immunomodulation for glioblastoma.

Reardon DA, Wen PY, Wucherpfennig KW, Sampson JH.

Curr Opin Neurol. 2017 Jun;30(3):361-369. doi: 10.1097/WCO.0000000000000451. Review.

PMID:
28368867
3.

[What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].

Schernberg A, Marabelle A, Massard C, Armand JP, Dumont S, Deutsch E, Dhermain F.

Bull Cancer. 2016 May;103(5):484-98. doi: 10.1016/j.bulcan.2016.02.014. Epub 2016 Mar 28. Review. French.

PMID:
27032303
4.

Developing immunotherapeutic strategies to target brain tumors.

Lieberman NA, Moyes KW, Crane CA.

Expert Rev Anticancer Ther. 2016 Jul;16(7):775-88. doi: 10.1080/14737140.2016.1192470. Epub 2016 Jun 13. Review.

PMID:
27253692
5.

Recent developments on immunotherapy for brain cancer.

Wainwright DA, Nigam P, Thaci B, Dey M, Lesniak MS.

Expert Opin Emerg Drugs. 2012 Jun;17(2):181-202. doi: 10.1517/14728214.2012.679929. Epub 2012 Apr 25. Review.

6.

Immunological Aspects of Malignant Gliomas.

Cohen-Inbar O, Zaaroor M.

Can J Neurol Sci. 2016 Jul;43(4):494-502. doi: 10.1017/cjn.2016.34. Review.

PMID:
27324313
7.

Advances in Immunotherapy for Glioblastoma Multiforme.

Huang B, Zhang H, Gu L, Ye B, Jian Z, Stary C, Xiong X.

J Immunol Res. 2017;2017:3597613. doi: 10.1155/2017/3597613. Epub 2017 Feb 19. Review.

8.

Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.

Polivka J Jr, Polivka J, Holubec L, Kubikova T, Priban V, Hes O, Pivovarcikova K, Treskova I.

Anticancer Res. 2017 Jan;37(1):21-33. Review.

PMID:
28011470
9.

Vaccine-based immunotherapy for glioblastoma.

Thomas AA, Fisher JL, Ernstoff MS, Fadul CE.

CNS Oncol. 2013 Jul;2(4):331-49. doi: 10.2217/cns.13.29. Review.

PMID:
25054578
10.

Concepts of immunotherapy for glioma.

Patel MA, Pardoll DM.

J Neurooncol. 2015 Jul;123(3):323-30. doi: 10.1007/s11060-015-1810-5. Epub 2015 Jun 13. Review.

11.

Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.

Ung N, Yang I.

J Neurooncol. 2015 Jul;123(3):473-81. doi: 10.1007/s11060-015-1814-1. Epub 2015 Jun 13. Review.

PMID:
26070553
12.

Immunotherapy for the treatment of glioblastoma.

Thomas AA, Ernstoff MS, Fadul CE.

Cancer J. 2012 Jan-Feb;18(1):59-68. doi: 10.1097/PPO.0b013e3182431a73. Review.

13.

Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.

Owyong M, Hosseini-Nassab N, Efe G, Honkala A, van den Bijgaart RJE, Plaks V, Smith BR.

Drug Resist Updat. 2017 Nov;33-35:23-35. doi: 10.1016/j.drup.2017.10.001. Epub 2017 Oct 14. Review.

PMID:
29145972
14.

Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.

Johanns TM, Dunn GP.

Cancer J. 2017 Mar/Apr;23(2):125-130. doi: 10.1097/PPO.0000000000000247. Review.

15.

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper.

Driggers L, Zhang JG, Newcomb EW, Ge L, Hoa N, Jadus MR.

J Neurooncol. 2010 Apr;97(2):159-69. doi: 10.1007/s11060-009-0016-0. Epub 2009 Oct 4. Review.

16.

Engineering challenges for brain tumor immunotherapy.

Lyon JG, Mokarram N, Saxena T, Carroll SL, Bellamkonda RV.

Adv Drug Deliv Rev. 2017 May 15;114:19-32. doi: 10.1016/j.addr.2017.06.006. Epub 2017 Jun 15. Review.

17.

Cellular-based immunotherapies for patients with glioblastoma multiforme.

Xu X, Stockhammer F, Schmitt M.

Clin Dev Immunol. 2012;2012:764213. doi: 10.1155/2012/764213. Epub 2012 Feb 28. Review.

18.

Cell- and peptide-based immunotherapeutic approaches for glioma.

Yamanaka R.

Trends Mol Med. 2008 May;14(5):228-35. doi: 10.1016/j.molmed.2008.03.003. Epub 2008 Apr 9. Review.

PMID:
18403264
19.

Cellular immunity and immunotherapy of brain tumors.

Prins RM, Liau LM.

Front Biosci. 2004 Sep 1;9:3124-36. Review.

PMID:
15353342
20.

The role of checkpoints in the treatment of GBM.

Kim JE, Lim M.

J Neurooncol. 2015 Jul;123(3):413-23. doi: 10.1007/s11060-015-1747-8. Epub 2015 Mar 7.

Supplemental Content

Support Center